Enliven Therapeutics, Inc. (ELVN) insider trading
Over the last 12 months, 0 insiders bought $0 and 10 insiders sold $76.9M of Enliven Therapeutics, Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- Oct 19, 2026: Collins Helen Louise sold 5,000 shares ($192K)
- Oct 19, 2026: Hohl Benjamin sold 6,018 shares ($232K)
- Oct 1, 2026: Garland J. Scott sold 13,000 shares ($607K)
- Sep 17, 2026: Collins Helen Louise sold 5,000 shares ($252K)
- Sep 17, 2026: Hohl Benjamin sold 6,018 shares ($303K)
- Aug 17, 2026: Hohl Benjamin sold 6,018 shares ($353K)
- Aug 17, 2026: Collins Helen Louise sold 5,000 shares ($293K)
- Aug 4, 2026: Derynck Mika K sold 158,795 shares ($9.56M)
- Jul 17, 2026: Collins Helen Louise sold 5,000 shares ($263K)
- Jul 17, 2026: Hohl Benjamin sold 6,018 shares ($317K)